| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0008 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0008 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.0009 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.099 | 0.001 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |